Riverhead Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $238K | Buy |
8,298
+400
| +5% | +$11.5K | 0.01% | 1057 |
|
|
2019
Q2 | $219K | Buy |
7,898
+400
| +5% | +$11.1K | 0.01% | 1110 |
|
|
2019
Q1 | $249K | Hold |
7,498
| – | – | 0.01% | 1022 |
|
|
2018
Q4 | $218K | Hold |
7,498
| – | – | 0.01% | 1031 |
|
|
2018
Q3 | $345K | Buy |
7,498
+400
| +6% | +$18.4K | 0.01% | 938 |
|
|
2018
Q2 | $265K | Hold |
7,098
| – | – | 0.01% | 954 |
|
|
2018
Q1 | $210K | Buy |
7,098
+1,100
| +18% | +$32.5K | 0.01% | 1046 |
|
|
2017
Q4 | $206K | Buy |
5,998
+1,000
| +20% | +$34.3K | 0.01% | 1056 |
|
|
2017
Q3 | $181K | Buy |
4,998
+837
| +20% | +$30.3K | 0.01% | 1030 |
|
|
2017
Q2 | $107K | Buy |
4,161
+1,861
| +81% | +$47.9K | 0.01% | 1193 |
|
|
2017
Q1 | $44K | Buy |
+2,300
| New | +$44K | ﹤0.01% | 1299 |
|